Skip to main content
Erschienen in: Obesity Surgery 7/2016

30.09.2015 | Original Contributions

Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric Surgery

verfasst von: Anne Sophie Schneck, Rodolphe Anty, Albert Tran, Audrey Hastier, Imed Ben Amor, Jean Gugenheim, Antonio Iannelli, Thierry Piche

Erschienen in: Obesity Surgery | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Only a few recent reports have suggested a correlation between obesity and irritable bowel syndrome (IBS). We aimed to determine the prevalence and severity of IBS in a prospective cohort of obese patients undergoing bariatric surgery in Nice Hospital (France).

Methods

One hundred obese patients were included prospectively before bariatric surgery. A diagnosis of IBS and each subtype was performed according to Rome-III criteria using a Bristol scale for stool consistency. Patients provided information on IBS-related comorbidities, including chronic fatigue, migraine, lower back pain, gastroesophageal reflux disease (GERD), genitourinary problems, and dyspepsia. Patients completed questionnaires to assess the severity of IBS, GERD, psychological factors (anxiety, depression), fatigue, and quality of life.

Results

Thirty patients fulfilled the Rome-III criteria for IBS. There was no difference in age, gender, or BMI between obese patients with or without IBS. Obese patients with IBS reported a significantly higher prevalence of GERD, migraines, lower back pain, genitourinary problems, chronic fatigue, and dyspepsia. Obese patients with IBS had significant higher scores of fatigue, anxiety, depression, and poorer quality of life. Obese patients that had both IBS and GERD had significantly higher IBS severity scores than those without GERD. In a logistic regression model including BMI, anxiety, depression, gender, and GERD score, only anxiety was significantly and independently associated with IBS.

Conclusions

Thirty percent of obese patients had IBS: its severity was not correlated with BMI. However, anxiety was independently associated with IBS, suggesting that psychological factors are key features of IBS, whatever the presence of obesity.
Literatur
1.
Zurück zum Zitat Hruby A, Hu FB. The Epidemiology of obesity: a big picture. Pharmacoeconomics. 2014. Hruby A, Hu FB. The Epidemiology of obesity: a big picture. Pharmacoeconomics. 2014.
2.
Zurück zum Zitat David K, Kowdley KV, Unalp A, et al. Schwimmer JB; NASH CRN Research Group. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49(6):1904–12.CrossRefPubMedPubMedCentral David K, Kowdley KV, Unalp A, et al. Schwimmer JB; NASH CRN Research Group. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49(6):1904–12.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Delgado-Aros S, Locke GR, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population based study. Am J Gastroenterol. 2004;99(9):1801–6.CrossRefPubMed Delgado-Aros S, Locke GR, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population based study. Am J Gastroenterol. 2004;99(9):1801–6.CrossRefPubMed
4.
Zurück zum Zitat Talley NJ, Quan C, Jones MP, et al. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;16(4):413–9.CrossRefPubMed Talley NJ, Quan C, Jones MP, et al. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;16(4):413–9.CrossRefPubMed
5.
Zurück zum Zitat Sadik R, Björnsson E, Simrén M. The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2010;22(1):102–8.CrossRefPubMed Sadik R, Björnsson E, Simrén M. The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2010;22(1):102–8.CrossRefPubMed
6.
Zurück zum Zitat Cremonini F, Camilleri M, Clark MM, et al. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes. 2009;33(3):342–53.CrossRef Cremonini F, Camilleri M, Clark MM, et al. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes. 2009;33(3):342–53.CrossRef
7.
Zurück zum Zitat Clements RH, Gonzalez QH, Foster A, et al. Mc- Dowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(4):610–4.CrossRefPubMed Clements RH, Gonzalez QH, Foster A, et al. Mc- Dowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(4):610–4.CrossRefPubMed
8.
Zurück zum Zitat Roberson EN, Gould JC, Wald A. Urinary and fecal incontinence after bariatric surgery. Dig Dis Sci. 2010;55(9):2606–13.CrossRefPubMed Roberson EN, Gould JC, Wald A. Urinary and fecal incontinence after bariatric surgery. Dig Dis Sci. 2010;55(9):2606–13.CrossRefPubMed
9.
Zurück zum Zitat Fysekidis M, Bouchoucha M, Bihan H, et al. Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery. Obes Surg. 2012;22(3):403–10.CrossRefPubMed Fysekidis M, Bouchoucha M, Bihan H, et al. Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery. Obes Surg. 2012;22(3):403–10.CrossRefPubMed
10.
Zurück zum Zitat Carter D, Beer-Gabel M, Tzur D, et al. Predictive factors for the diagnosis of irritable bowel syndrome in a large cohort of 440,822 young adults. Clin Gastroenterol. 2015;49(4):300–5.CrossRef Carter D, Beer-Gabel M, Tzur D, et al. Predictive factors for the diagnosis of irritable bowel syndrome in a large cohort of 440,822 young adults. Clin Gastroenterol. 2015;49(4):300–5.CrossRef
11.
Zurück zum Zitat Iannelli A, Anty R, Piche T, et al. Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women. Obes Surg. 2009;19(5):577–82.CrossRefPubMed Iannelli A, Anty R, Piche T, et al. Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women. Obes Surg. 2009;19(5):577–82.CrossRefPubMed
12.
Zurück zum Zitat Anty R, Dahman M, Iannelli A, et al. Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg. 2008;18(6):709–14.CrossRefPubMed Anty R, Dahman M, Iannelli A, et al. Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg. 2008;18(6):709–14.CrossRefPubMed
13.
Zurück zum Zitat NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61.
14.
Zurück zum Zitat Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–91.CrossRefPubMed Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–91.CrossRefPubMed
15.
Zurück zum Zitat Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395–402.CrossRefPubMed Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395–402.CrossRefPubMed
16.
Zurück zum Zitat Piche T, Ducrotté P, Sabate JM, et al. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(6):626–e174.CrossRefPubMed Piche T, Ducrotté P, Sabate JM, et al. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(6):626–e174.CrossRefPubMed
17.
Zurück zum Zitat Fisk JD, Pontrefact A, Ritvo PF, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Can J Neurol Sci. 1994;18 Suppl 1:S79–83. Fisk JD, Pontrefact A, Ritvo PF, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Can J Neurol Sci. 1994;18 Suppl 1:S79–83.
18.
Zurück zum Zitat Huet PM, Deslauriers J, Tran A, et al. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol. 2000;95(3):760–7.CrossRefPubMed Huet PM, Deslauriers J, Tran A, et al. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol. 2000;95(3):760–7.CrossRefPubMed
19.
Zurück zum Zitat Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed
20.
Zurück zum Zitat Piche T, Saint-Paul MC, Dainese R, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut. 2008;57(4):468–73.CrossRefPubMed Piche T, Saint-Paul MC, Dainese R, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut. 2008;57(4):468–73.CrossRefPubMed
21.
Zurück zum Zitat Sacher-Huvelin S, Gournay J, Amouretti M, et al. Bruley Des Varannes S, Galmiche JP. Acid-sensitive esophagus: natural history and effect on the quality of life. Comparison with gastroesophageal reflux. Gastroenterol Clin Biol. 2000;24(10):911–6.PubMed Sacher-Huvelin S, Gournay J, Amouretti M, et al. Bruley Des Varannes S, Galmiche JP. Acid-sensitive esophagus: natural history and effect on the quality of life. Comparison with gastroesophageal reflux. Gastroenterol Clin Biol. 2000;24(10):911–6.PubMed
22.
Zurück zum Zitat Dapoigny M, Bellanger J, Bonaz B. Bruley des Varannes S, Bueno L, Coffin B, et al. Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol. 2004;16(10):995–1001.CrossRefPubMed Dapoigny M, Bellanger J, Bonaz B. Bruley des Varannes S, Bueno L, Coffin B, et al. Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol. 2004;16(10):995–1001.CrossRefPubMed
23.
Zurück zum Zitat Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125(6):1651–9.CrossRefPubMed Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125(6):1651–9.CrossRefPubMed
24.
Zurück zum Zitat Marshall JK, Thabane M, Garg AX, et al. Collins SM; Walkerton Health Study Investigators. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010;59(5):605–11.CrossRefPubMed Marshall JK, Thabane M, Garg AX, et al. Collins SM; Walkerton Health Study Investigators. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010;59(5):605–11.CrossRefPubMed
25.
Zurück zum Zitat Scarpellini E, Lupo M, Iegri C, et al. Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis. Rev Recent Clin Trials. 2014;9(3):141–7.PubMed Scarpellini E, Lupo M, Iegri C, et al. Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis. Rev Recent Clin Trials. 2014;9(3):141–7.PubMed
26.
Zurück zum Zitat Ma YY, Li L, Yu CH, et al. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol. 2013;19(40):6911–8.CrossRefPubMedPubMedCentral Ma YY, Li L, Yu CH, et al. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol. 2013;19(40):6911–8.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(10):1547–61.CrossRefPubMed Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(10):1547–61.CrossRefPubMed
Metadaten
Titel
Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric Surgery
verfasst von
Anne Sophie Schneck
Rodolphe Anty
Albert Tran
Audrey Hastier
Imed Ben Amor
Jean Gugenheim
Antonio Iannelli
Thierry Piche
Publikationsdatum
30.09.2015
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 7/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1907-0

Weitere Artikel der Ausgabe 7/2016

Obesity Surgery 7/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.